• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Scientists discover genes that help harmful bacteria thwart treatment

Bioengineer by Bioengineer
February 8, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Two genes may make staph infections resistant to copper, a powerful antibacterial agent

IMAGE

Credit: U.S. Centers for Disease Control and Prevention


A Rutgers-led team has discovered two genes that make some strains of harmful Staphyloccocus bacteria resistant to treatment by copper, a potent and frequently used antibacterial agent.

The discovery shows that Staphyloccocus aureus can acquire additional genes that promote infections and antibacterial resistance and may open new paths for the development of antibacterial drugs, according to a study in the Journal of Biological Chemistry.

Researchers at Rutgers University-New Brunswick found the two genes in some strains of S. aureus bacteria. The genes protect the germs from copper, which is increasingly used in the global fight against severe infections.

The Staphylococcus aureus bacterium – a leading cause of serious and life-threatening infections in the United States – is highly resistant to antibiotics. Some strains of S. aureus have newly acquired genes embedded in their genome in pieces of DNA called transposons. DNA can be transferred from one organism to another, and transposons help the acquired DNA rapidly become a permanent part of the recipient’s chromosome.

Transposons aid in the spread of genes that can give rise to bacteria that are resistant to antibiotics and more likely to cause disease. The newly discovered genes are encoded within a transposon.

This process likely contributed to the recent North American epidemic of staph infections, according to Jeffrey M. Boyd, study senior author and associate professor in the Department of Biochemistry and Microbiology in Rutgers’ School of Environmental and Biological Sciences.

Copper has been used for thousands of years to sterilize wounds and drinking water, and hospitals recently began using it against bacteria found on medical instruments and other surfaces. But the two newly discovered genes, named copB and copL, encode proteins that help remove copper from S. aureus cells and prevent it from entering.

The genes may promote the survival of S. aureus in settings, such as in hospitals, that could lead to infections – and/or they may lead to S. aureus strains with higher copper resistance.

S. aureus bacteria live on skin. They are a leading cause of serious and life-threatening infections partly because many strains of S. aureus, such as MRSA and VRSA, are highly resistant to antibiotics.

Rutgers scientists, in collaboration with scientists at the University of Buffalo, also revealed the 3D structure of the copL protein in the B. subtilis bacterium, a relative of S. aureus, using nuclear magnetic resonance (NMR) methods. Those methods were also used to identify the area where copper binds to the surface of the protein.

“This structure provides the basis for rational drug design and could lead to a novel path for antibacterial drug discovery,” said co-author Gaetano T. Montelione, Jerome and Lorraine Aresty Chair and a Distinguished Professor in the Department of Molecular Biology and Biochemistry in the School of Arts and Sciences. He is also affiliated with the Center for Advanced Biotechnology and Medicine.

###

The study was conducted mainly by Rutgers students Zuelay Rosario-Cruz, Nourhan Daigham and Hassan Al-Tameemi, together with University at Buffalo (UB) staff scientist Alexander Eletsky. Rutgers Professor Peter Kahn and staff scientist G.V.T. Swapna, together with UB Distinguished Professor Thomas Szyperski, also contributed.

Media Contact
Todd Bates
[email protected]
848-932-0550

Original Source

https://news.rutgers.edu/scientists-discover-genes-help-harmful-bacteria-thwart-treatment/20190207#.XFx-mFxKi70

Related Journal Article

http://dx.doi.org/10.1074/jbc.RA118.004723

Tags: BiochemistryCell BiologyGeneticsInfectious/Emerging DiseasesMedicine/HealthMicrobiologyMolecular BiologyPharmaceutical SciencePublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Gordian Biotechnology Named Tier 5 Sponsor for ARDD 2025

August 8, 2025
Special Journal Issue Highlights Disability in the Black Community and Urges Culturally Tailored Counseling Approaches

Special Journal Issue Highlights Disability in the Black Community and Urges Culturally Tailored Counseling Approaches

August 8, 2025

In-Depth Analysis of Clubfoot Causes and Treatment Advances

August 8, 2025

UC Study Reveals Connection Between Childhood Trauma and Tobacco Exposure

August 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    121 shares
    Share 48 Tweet 30
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    76 shares
    Share 30 Tweet 19
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    52 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mapping Urban Slums Reveals Inequality in Africa

Newborn Idiopathic Scrotal Hematoma: Case Study Insights

Gordian Biotechnology Named Tier 5 Sponsor for ARDD 2025

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.